Malaria Prevention for Travelers

Prophylaxis Options, Drug Resistance & Bite Prevention Strategies

What Every Traveler Must Know

Malaria is one of the most serious infections acquired during international travel. Despite being entirely preventable, it kills over 600,000 people annually. American travelers visiting malaria-endemic regions are at significant risk because they have no natural immunity and may underestimate the danger.

The good news: with the right combination of antimalarial medication and bite prevention measures, malaria is highly preventable. This guide covers everything you need to know before traveling to a malaria-risk region.

100+ Countries Malaria transmission occurs across tropical and subtropical regions worldwide

Zero Natural Immunity American travelers have no pre-existing immunity — even brief exposure carries risk

4 Prophylaxis Options Different drugs suit different destinations, health profiles, and trip lengths

Highly Preventable Correct chemoprophylaxis plus bite prevention reduces risk by over 90%

Full country-by-country malaria risk data: See our dedicated malaria risk directory at FitToTravel.net — Malaria Risk Countries →

Understanding Malaria

Malaria is caused by Plasmodium parasites transmitted to humans through the bite of infected female Anopheles mosquitoes. Five species infect humans, but P. falciparum is by far the most dangerous, responsible for the vast majority of severe cases and deaths. P. vivax is the most geographically widespread.

      
      Incubation period: Symptoms typically appear 7–30 days after the infectious bite. P. vivax and P. ovale can lie dormant in the liver and reactivate months or even years later.
    

Key warning for returning travelers: Any fever developing within 3 months of returning from a malaria-risk area must be treated as malaria until proven otherwise. Seek medical attention immediately — do not wait.

Malaria Symptoms to Watch For

High fever — often with cyclical pattern (every 48–72 hrs)
Chills and rigors — intense shaking episodes
Severe headache
Muscle aches and fatigue
Nausea, vomiting, diarrhoea
Sweating following fever spikes
Anaemia and jaundice in severe cases

P. falciparum malaria can progress to cerebral malaria, organ failure, and death within 24–48 hours of symptom onset. Treat as a medical emergency.

Who Needs Malaria Prophylaxis?

All Travelers to Endemic Areas

Any traveler visiting sub-Saharan Africa, South/Southeast Asia, parts of Latin America, Oceania, or the Middle East where malaria transmission occurs — regardless of trip length.

Business & Short-Stay Travelers

Even a single night in a malaria-risk area carries exposure risk. Business travelers who stay in air-conditioned urban hotels still require prophylaxis if visiting high-risk countries.

Adventure & Rural Travelers

Camping, hiking, safari, and rural travel dramatically increases exposure to infected mosquitoes — particularly at dawn and dusk. Risk is highest outside of urban centres.

Children & Pregnant Travelers

Children and pregnant women are at highest risk of severe malaria. Pregnancy and malaria interact dangerously — pregnant travelers should ideally avoid high-risk destinations.

Travelers with Medical Conditions

Immunosuppressed travelers, those with asplenia, HIV, or chronic illness face increased risk of severe malaria. Drug choice requires careful medical review.

Visiting Friends & Relatives (VFR)

Travelers visiting family in endemic countries often mistakenly believe prior exposure provides immunity or that they "know the risks." VFR travelers account for a disproportionately high percentage of imported malaria cases.

Antimalarial Prophylaxis Options

Prescription required: All antimalarial medications require a prescription in the United States. See a travel medicine physician at least 4–6 weeks before departure — some drugs require loading before travel begins.

Atovaquone-Proguanil (Malarone)

First Choice

Start / Stop TimingStart 1–2 days before entering a risk area. Continue for 7 days after leaving. Ideal for short trips.

DosingOnce daily with food or a milky drink. Same time each day.

Best ForMost destinations including sub-Saharan Africa, Southeast Asia, South America. Effective against P. falciparum and most resistance patterns.

Not Suitable ForSevere renal impairment. Not recommended for long-term use (>1 year). Cost can be higher than alternatives.

Side EffectsGenerally well tolerated. Abdominal pain, nausea, headache in some users. Take with food to minimise GI effects.

Pregnancy / ChildrenNot recommended in first trimester or breastfeeding infants under 5 kg. Safe for children over 11 kg (paediatric tablets available).

Best choice for most US travelers — short pre-travel lead time, once daily, stops just 7 days post-trip, and widely effective across drug-resistant regions.

Doxycycline

First Choice — Budget Option

Start / Stop TimingStart 1–2 days before entering a risk area. Continue for 4 weeks after leaving the risk area.

DosingOnce daily with a full glass of water, with food. Take at the same time each day. Do not lie down for 30 minutes after taking.

Best ForAll malaria-risk destinations. Also provides additional protection against rickettsial diseases and leptospirosis — useful for jungle/rural travel.

Not Suitable ForPregnancy, breastfeeding, and children under 8 years. Requires strict sun protection — increases photosensitivity significantly.

Side EffectsPhotosensitivity (sunburn risk), oesophageal irritation, vaginal candidiasis in women. Take upright with plenty of water to prevent oesophagitis.

CostSignificantly cheaper than Malarone — widely available as generic. Good option for longer trips where Malarone cost is prohibitive.

Best value option for longer trips. Also the preferred choice for travelers to areas where doxycycline provides dual coverage against other insect-borne infections.

Mefloquine (Lariam)

Weekly Dosing

Start / Stop TimingStart 2–3 weeks before travel — this allows time to identify neuropsychiatric side effects before departure. Continue for 4 weeks after leaving.

DosingOnce weekly on the same day each week. Take with food and water.

Best ForLong-term travelers and those visiting areas where Malarone or doxycycline are less practical. Weekly dosing suits some longer itineraries.

Not Suitable ForHistory of psychiatric disorders, seizures, cardiac conduction abnormalities, or certain medications. Contraindicated for mefloquine-resistant destinations.

Side EffectsVivid dreams, dizziness, anxiety, neuropsychiatric reactions in a minority of users. FDA black box warning for neuropsychiatric effects. Must start early to screen for tolerability.

Pregnancy / ChildrenCan be used in pregnancy if benefit outweighs risk. Approved for children over 5 kg.

Due to neuropsychiatric side effects, mefloquine is now a second-line option for most travelers. Discuss suitability carefully with your travel medicine physician.

Chloroquine / Hydroxychloroquine

Limited Use Areas Only

Start / Stop TimingStart 1–2 weeks before travel. Continue for 4 weeks after leaving the risk area.

DosingOnce weekly on the same day. Take with food to reduce nausea.

Best ForOnly effective in areas with chloroquine-sensitive malaria — Central America (west of Panama Canal), Haiti, Dominican Republic, parts of the Middle East.

Not Suitable ForCannot be used in Africa, South/Southeast Asia, or South America due to widespread P. falciparum chloroquine resistance. Retinal toxicity with long-term use.

Side EffectsGenerally well tolerated. GI upset, headache, dizziness. Retinal toxicity is a concern only with long-term use.

Pregnancy / ChildrenSafe to use in pregnancy and children when indicated. One of the few options considered safe throughout pregnancy.

Chloroquine resistance is widespread — this drug is ineffective for most malaria-risk destinations. Only use when specifically recommended for your itinerary by a travel medicine physician.

Drug	Start Before Travel	Stop After Travel	Dosing	Best For	Pregnancy
Atovaquone-Proguanil (Malarone)	1–2 days	7 days	Daily	Most destinations	Avoid 1st trimester
Doxycycline	1–2 days	4 weeks	Daily	All destinations — budget option	Avoid
Mefloquine (Lariam)	2–3 weeks	4 weeks	Weekly	Long trips; 2nd line	Use with caution
Chloroquine	1–2 weeks	4 weeks	Weekly	Chloroquine-sensitive areas only	Safe

Drug Resistance by Region

Drug resistance is one of the most critical factors in choosing antimalarial prophylaxis. P. falciparum — the most deadly malaria species — has developed resistance to multiple drug classes across different regions. Always check current CDC and WHO resistance maps before departure.

🌍

Sub-Saharan Africa

High Risk P. falciparum Dominant

Resistance profile: Widespread chloroquine resistance. Increasing artemisinin partial resistance emerging in parts of East Africa (reported in Rwanda, Uganda).

Recommended: Atovaquone-proguanil or doxycycline. Mefloquine for long stays.

🌏

Southeast Asia

High Risk Multi-Drug Resistance

Resistance profile: The Greater Mekong Subregion (Myanmar, Thailand, Cambodia, Laos, Vietnam) has the most drug-resistant malaria in the world — including artemisinin and multi-drug resistance.

Recommended: Atovaquone-proguanil or doxycycline. Avoid mefloquine in Thailand, Cambodia, and Myanmar.

🐘

South Asia (India, Nepal, Pakistan)

Moderate–High Risk

Resistance profile: Mixed P. falciparum and P. vivax. Chloroquine resistance widespread in P. falciparum. Some chloroquine resistance in P. vivax in parts of India.

Recommended: Atovaquone-proguanil or doxycycline.

🌎

Latin America

Variable Risk by Country

Resistance profile: Chloroquine resistance in P. falciparum throughout South America. Chloroquine-sensitive P. vivax in most areas. Haiti and Dominican Republic remain chloroquine-sensitive.

Recommended: Atovaquone-proguanil or doxycycline for most of South America. Chloroquine options for Haiti/Dominican Republic.

🕌

Middle East

Low–Moderate Risk

Resistance profile: Mainly P. vivax with chloroquine sensitivity in most areas. Risk limited to specific rural regions — many popular tourist destinations are malaria-free.

Recommended: Chloroquine where indicated. Confirm destination-specific risk before prescribing.

🦘

Oceania (PNG & Solomon Islands)

High Risk in PNG

Resistance profile: Papua New Guinea has high malaria burden with chloroquine-resistant P. falciparum and P. vivax. Australia and New Zealand are malaria-free.

Recommended: Atovaquone-proguanil or doxycycline for PNG and Solomon Islands.

Full country-by-country malaria risk and resistance data: FitToTravel.net — Malaria Risk Countries Directory → · CDC Destination-Specific Recommendations →

Bite Prevention Strategies

Antimalarial drugs significantly reduce — but do not completely eliminate — the risk of malaria. Bite prevention is an equally critical layer of protection. Anopheles mosquitoes primarily bite between dusk and dawn, so evening and overnight precautions are most important.

DEET-Based Insect Repellent

The most effective and well-studied repellent for malaria prevention. Apply to all exposed skin.

20–50% DEET Reapply every 4–6 hrs Safe in pregnancy

30–50% DEET is recommended for malaria-endemic areas. Safe for children over 2 months at concentrations up to 30%.

Protective Clothing

Long-sleeved shirts, long trousers, and closed-toe shoes at dawn and dusk. Light-coloured clothing is preferred.

Long sleeves & trousers Light colours Permethrin-treated

Treating clothing with permethrin (0.5% spray or pre-treated clothing) kills mosquitoes on contact and remains effective through multiple washes.

Insecticide-Treated Bed Nets (ITN)

Essential for sleeping in areas without air conditioning or intact window screens. Long-lasting insecticidal nets (LLINs) are preferred.

LLIN preferred No holes or tears Tuck under mattress

Even if accommodation provides air conditioning, carry a travel bed net for rural stays, camping, or power outages.

Accommodation Precautions

Stay in well-screened or air-conditioned accommodation where possible. Mosquitoes do not thrive in air-conditioned environments.

Air conditioning Window screens Room sprays

Use a room spray or plug-in insecticide device (pyrethroid-based) in bedrooms before dusk. Keep windows and doors closed after dark.

Behavioural Precautions — Timing

Anopheles mosquitoes are peak biters from dusk to dawn. Adjust outdoor activity accordingly.

Avoid outdoor exposure dusk–dawn Cover up from 6pm

Apply repellent before going outdoors in the evening, even for short periods — one bite is sufficient for infection.

Environmental Controls

Avoid standing water near accommodation where possible — stagnant water is a breeding ground for Anopheles mosquitoes.

Empty standing water Avoid water bodies at dusk

Rural, jungle, and waterside accommodation carries significantly higher mosquito exposure than urban air-conditioned hotels.

Repellent Type	Effectiveness	Duration	Safe in Pregnancy?	Notes
DEET (30–50%)	⭐⭐⭐⭐⭐ Highest	4–8 hours	Yes (2nd/3rd trimester)	Gold standard — recommended by CDC & WHO
Picaridin (20%)	⭐⭐⭐⭐ High	8–12 hours	Yes	Odourless, less greasy than DEET. Good alternative.
IR3535 (20%)	⭐⭐⭐ Moderate	4–6 hours	Yes	Widely used in Europe. Less evidence in malaria regions.
Oil of Lemon Eucalyptus (OLE)	⭐⭐⭐ Moderate	4–6 hours	Not recommended under 3 yrs	Plant-based CDC-approved option. Not for young children.
Permethrin (clothing)	⭐⭐⭐⭐ High	Multiple washes	Avoid direct skin application	Kills mosquitoes on contact. Apply to clothing only, not skin.

Special Populations

Pregnant Travelers

Malaria during pregnancy causes severe maternal illness, miscarriage, premature delivery, and stillbirth. Ideally, avoid all malaria-risk travel during pregnancy. If travel is unavoidable: mefloquine and chloroquine are the preferred options by trimester — atovaquone-proguanil is avoided in the first trimester, doxycycline throughout.

Children

Children are at high risk of severe and fatal malaria. Atovaquone-proguanil (paediatric tablets) and mefloquine are available for children. Doxycycline is avoided under 8 years. DEET up to 30% is safe for children over 2 months. Bed nets are critical for children sleeping in endemic areas.

Immunocompromised Travelers

Travelers with HIV, on immunosuppressants, or with asplenia face increased severity of malaria. Drug interactions must be carefully screened — atovaquone may interact with certain antiretrovirals. Specialist travel medicine review is essential.

Older Travelers

Older travelers may have more drug interactions and comorbidities affecting prophylaxis choice. Cardiac conditions affect mefloquine suitability. Renal function affects atovaquone-proguanil dosing. A full medication review before prescribing is essential.

If You Develop Fever During or After Travel

Any fever within 3 months of return from a malaria-risk area is malaria until proven otherwise. Do not wait for symptoms to worsen — seek emergency medical attention immediately and inform the treating physician of your travel history.

Seek Urgent Medical Care

Go to an emergency room or urgent care clinic immediately. Tell them you have recently traveled to a malaria-risk area. Request a malaria blood smear and rapid diagnostic test (RDT).

Confirm the Species

Treatment differs by Plasmodium species. P. falciparum requires urgent artemisinin-based combination therapy (ACT). P. vivax and P. ovale also require primaquine to prevent relapse.

Standby Emergency Treatment (SBET)

For travelers to very remote areas where medical care is >24 hours away, your travel physician may prescribe a course of treatment-dose antimalarials to carry for emergency self-treatment. This is a last resort — not a substitute for prophylaxis.

A Note from the Medical Editor

Malaria prevention requires a personalised approach — there is no single drug or strategy that fits all travelers and all destinations. The combination of the right chemoprophylaxis for your specific itinerary, rigorous bite prevention, and awareness of the symptoms is what keeps travelers safe. Start your pre-travel consultation early enough to allow for the loading period of your chosen prophylaxis.

For full country-by-country malaria risk data, current outbreak alerts, and destination-specific prophylaxis recommendations, visit our dedicated resource: FitToTravel.net — Malaria Risk Countries →

Medical Disclaimer: This article provides general travel health education only and does not constitute individual medical advice. Malaria risk and drug resistance patterns change — always confirm current recommendations with the CDC, WHO, and your travel medicine physician before departure. Contact us at This email address is being protected from spambots. You need JavaScript enabled to view it. with any questions.

Sources & further reading: CDC Yellow Book — Malaria · WHO Malaria Fact Sheet · FitToTravel.net — Malaria Risk Countries · ISTM Guidelines

Explore the Malaria Risk Map
View countries with malaria transmission risk and find out where antimalarial medication and mosquito bite prevention are recommended before you travel.
View the Malaria Risk Map